{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:37:45Z","timestamp":1791239865068,"version":"4.1.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA033067"],"award-info":[{"award-number":["R01DA033067"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA021471"],"award-info":[{"award-number":["R01AA021471"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ann. behav. med."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12160-016-9827-3","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T16:03:46Z","timestamp":1470845026000},"page":"67-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Barriers to HIV Medication Adherence as a Function of Regimen Simplification"],"prefix":"10.1093","volume":"51","author":[{"given":"Yiyun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth C.","family":"Kalichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"issue":"9635","key":"9827_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"Antiretroviral Therapy Cohort, C","year":"2008","unstructured":"Antiretroviral Therapy Cohort, C., Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008; 372(9635): 293\u20139.","journal-title":"Lancet"},{"issue":"1","key":"9827_CR2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/QAI.0b013e3181b563e7","volume":"53","author":"KM Harrison","year":"2010","unstructured":"Harrison, K.M., R. Song, and X. Zhang, Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 2010; 53(1): 124\u201330.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"9827_CR3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen, M.S., et al., Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Engl J Med 2011; 365(6): 493\u2013505.","journal-title":"N Engl J Med"},{"issue":"9","key":"9827_CR4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","volume":"15","author":"DR Bangsberg","year":"2001","unstructured":"Bangsberg, D.R., et al., Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001; 15(9):1181\u20133.","journal-title":"AIDS"},{"issue":"8","key":"9827_CR5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7326\/0003-4819-146-8-200704170-00007","volume":"146","author":"JB Nachega","year":"2007","unstructured":"Nachega, J.B., et al., Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007;146(8): 564\u201373.","journal-title":"Ann Intern Med"},{"issue":"3","key":"9827_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.qai.0000197071.77482.6e","volume":"41","author":"H Liu","year":"2006","unstructured":"Liu, H., et al., Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr 2006;41(3): 315\u201322.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"9827_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/apc.2006.20.48","volume":"20","author":"G Parruti","year":"2006","unstructured":"Parruti, G., et al., Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse. AIDS Patient Care STDs 2006; 20(1): 48\u201356.","journal-title":"AIDS Patient Care STDs"},{"issue":"Suppl 3","key":"9827_CR8","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1086\/533415","volume":"197","author":"DR Bangsberg","year":"2008","unstructured":"Bangsberg, D.R., Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis 2008; 197 Suppl 3: S272\u20138.","journal-title":"J Infect Dis"},{"key":"9827_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/PPA.S22771","volume":"5","author":"JB Nachega","year":"2011","unstructured":"Nachega, J.B., et al., Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs. Patient Prefer Adherence. 2011; 5: 357\u201367.","journal-title":"Patient Prefer Adherence."},{"issue":"3","key":"9827_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","volume":"354","author":"JE Gallant","year":"2006","unstructured":"Gallant, J.E., et al., Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med 2006; 354(3): 251\u201360.","journal-title":"N Engl J Med"},{"issue":"9787","key":"9827_CR11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(11)60983-5","volume":"378","author":"CJ Cohen","year":"2011","unstructured":"Cohen, C.J., et al., Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. Lancet 2011; 378(9787): 229\u201337.","journal-title":"Lancet"},{"issue":"9835","key":"9827_CR12","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0140-6736(12)60917-9","volume":"379","author":"PE Sax","year":"2012","unstructured":"Sax, P.E., et al., Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks. Lancet 2012; 379(9835):2439\u201348.","journal-title":"Lancet"},{"issue":"4","key":"9827_CR13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/596482","volume":"48","author":"JJ Parienti","year":"2009","unstructured":"Parienti, J.J., et al., Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis 2009; 48(4): 484\u20138.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"9827_CR14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/cid\/ciu046","volume":"58","author":"JB Nachega","year":"2014","unstructured":"Nachega, J.B., et al., Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV infection: A Meta-Analysis of Randomized Controlled Trials. Clin Infect Dis 2014; 58(9):1297\u2013307.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"9827_CR15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/09540121.2010.534433","volume":"23","author":"V Cooper","year":"2011","unstructured":"Cooper, V., et al., Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine\/lamivudine or switch to tenofovir DF\/emtricitabine, each with efavirenz. AIDS Care 2011; 23(6): 705\u201313.","journal-title":"AIDS Care"},{"issue":"18","key":"9827_CR16","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1097\/QAD.0b013e328340a209","volume":"24","author":"DR Bangsberg","year":"2010","unstructured":"Bangsberg, D.R., et al., A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS 2010; 24(18): 2835\u201340.","journal-title":"AIDS"},{"issue":"5","key":"9827_CR17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/QAI.0000000000000082","volume":"65","author":"DB Hanna","year":"2014","unstructured":"Hanna, D.B., et al., Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr 2014; 65(5): 587\u201396.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9827_CR18","doi-asserted-by":"crossref","unstructured":"Cohen, C.J., J.L. Meyers, and K.L. Davis, Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV. BMJ Open. 2013; 3(8).","DOI":"10.1136\/bmjopen-2013-003028"},{"key":"9827_CR19","doi-asserted-by":"crossref","unstructured":"Rao, G.A., et al., Impact of Highly Active Antiretroviral Therapy Regimen on Adherence and Risk of Hospitalization in Veterans with HIV\/AIDS. Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado, USA; 2013.","DOI":"10.1016\/j.jval.2013.08.112"},{"issue":"2","key":"9827_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1310\/hct0902-103","volume":"9","author":"E DeJesus","year":"2008","unstructured":"DeJesus, E., et al., Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine\/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate\/emtricitabine. HIV Clin Trials 2008; 9(2): 103\u201314.","journal-title":"HIV Clin Trials"},{"key":"9827_CR21","first-page":"115","volume":"4","author":"M Airoldi","year":"2010","unstructured":"Airoldi, M., et al., One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Prefer Adherence 2010; 4:115\u201325.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"9827_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAI.0b013e3181a572cf","volume":"51","author":"E Dejesus","year":"2009","unstructured":"Dejesus, E., et al., Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. J Acquir Immune Defic Syndr 2009; 51(2):163\u201374.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"9827_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/apc.2009.0259","volume":"24","author":"SL Hodder","year":"2010","unstructured":"Hodder, S.L., et al., Patient-reported outcomes in virologically suppressed, HIV-1-infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir. AIDS Patient Care STDs 2010; 24(2): 87\u201396.","journal-title":"AIDS Patient Care STDs"},{"issue":"5","key":"9827_CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1258\/ijsa.2011.011292","volume":"23","author":"A Buscher","year":"2012","unstructured":"Buscher, A., et al., Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. Int J STD AIDS 2012; 23(5):351\u20135.","journal-title":"Int J STD AIDS"},{"key":"9827_CR25","unstructured":"Engsig, F., et al., Virological Response in Patients, Who for Economic Reasons Were Changed from Atripla to a Multi-tablet cART Regimen 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, GA, USA; 2013."},{"issue":"1","key":"9827_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/2325957414555228","volume":"14","author":"SJ Tennant","year":"2015","unstructured":"Tennant, S.J., et al., Adherence among rural HIV-infected patients in the deep south: a comparison between single-tablet and multi-tablet once-daily regimens. J Int Assoc Provid AIDS Care 2015; 14(1): 64\u201371.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"9827_CR27","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2015."},{"issue":"11","key":"9827_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111421","volume":"9","author":"I Hodgson","year":"2014","unstructured":"Hodgson, I., et al., A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One 2014; 9(11): e111421.","journal-title":"PLoS One"},{"issue":"3 Suppl 2","key":"9827_CR29","doi-asserted-by":"crossref","first-page":"18640","DOI":"10.7448\/IAS.16.3.18640","volume":"16","author":"IT Katz","year":"2013","unstructured":"Katz, I.T., et al., Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc 2013;16(3 Suppl 2): 18640.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"9827_CR30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/QAI.0b013e3181b18b6e","volume":"52","author":"CS Hendershot","year":"2009","unstructured":"Hendershot, C.S., et al., Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 2009; 52(2): 180\u2013202.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6\u20138","key":"9827_CR31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10826080009148425","volume":"35","author":"JN Gribble","year":"2000","unstructured":"Gribble, J.N., et al., The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Subst Use Misuse 2000; 35(6\u20138):869\u201390.","journal-title":"Subst Use Misuse"},{"issue":"5","key":"9827_CR32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10461-006-9081-y","volume":"10","author":"D Morrison-Beedy","year":"2006","unstructured":"Morrison-Beedy, D., M.P. Carey, and X. Tu, Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior. AIDS Behav 2006; 10(5): 541\u201352.","journal-title":"AIDS Behav"},{"issue":"9","key":"9827_CR33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1258\/0956462001916551","volume":"11","author":"SC Kalichman","year":"2000","unstructured":"Kalichman, S.C., D. Rompa, and M. Cage, Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV\/AIDS. Int J STD AIDS, 2000. 11(9): 579\u201385.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"9827_CR34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff, L.S., The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas, 1977. 1(3): p. 385\u2013401.","journal-title":"Appl Psychol Meas"},{"key":"9827_CR35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1011396711486","volume":"5","author":"DR Bangsberg","year":"2001","unstructured":"Bangsberg, D.R., et al., Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav, 2001. 5: p. 275\u2013281.","journal-title":"AIDS Behav"},{"key":"9827_CR36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1310\/hct0905-298","volume":"9","author":"SC Kalichman","year":"2008","unstructured":"Kalichman, S.C., et al., Monitoring Antiretroviral adherence by unannounced pill counts conducted by telephone: Reliability and criterion-related validity. HIV Clin Trials 2008. 9: p. 298\u2013308.","journal-title":"HIV Clin Trials"},{"key":"9827_CR37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s11606-007-0171-y","volume":"22","author":"SC Kalichman","year":"2007","unstructured":"Kalichman, S.C., et al., Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med 2007. 22: p. 1003\u20131006.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"9827_CR38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002030-200003100-00008","volume":"14","author":"DR Bangsberg","year":"2000","unstructured":"Bangsberg, D.R., et al., Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 2000. 14(4): 357\u201366.","journal-title":"AIDS"},{"issue":"2","key":"9827_CR39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1037\/0278-6133.19.2.124","volume":"19","author":"SL Catz","year":"2000","unstructured":"Catz, S.L., et al., Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol, 2000. 19(2): 124\u201333.","journal-title":"Health Psychol"},{"key":"9827_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/01621459.1981.10477633","volume":"76","author":"JNK Rao","year":"1981","unstructured":"Rao, J.N.K. and A.J. Scott, The analysis of categorical data from complex sample surveys: chi-squared tests for goodness-of-fit and independence in two-way tables. J Am Stat Assoc, 1981;76: 221\u2013230.","journal-title":"J Am Stat Assoc"},{"key":"9827_CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1037\/0882-7974.12.2.277","volume":"12","author":"PM Lewinsohn","year":"1997","unstructured":"Lewinsohn, P.M., et al., Center for Epidemiological Studies-Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging, 1997. 12: p. 277\u2013287.","journal-title":"Psychol Aging"},{"key":"9827_CR42","unstructured":"Chesney, M.A. Compliance: How Physicians Can Help. 1997 [cited 2015 November 12, 2015]; Available from: http:\/\/arv.ucsf.edu\/hiv?page=md-kbr-03-02-09 ."},{"issue":"4","key":"9827_CR43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1055-3290(06)60217-3","volume":"12","author":"SC Kalichman","year":"2001","unstructured":"Kalichman, S.C., et al., HIV treatment adherence in women living with HIV\/AIDS: research based on the information-motivation-behavioral skills model of health behavior. J Assoc Nurses AIDS Care, 2001. 12(4): p. 58\u201367.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"1","key":"9827_CR44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger, S.L. and K.Y. Liang, Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 1986. 42(1): p. 121\u201330.","journal-title":"Biometrics"},{"issue":"5","key":"9827_CR45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00126334-200004150-00005","volume":"23","author":"AL Gifford","year":"2000","unstructured":"Gifford, A.L., et al., Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr, 2000. 23(5): p. 386\u201395.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9827_CR46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. and Y. Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Met, 1995. 57: p. 289\u2013300.","journal-title":"J R Stat Soc B Met"},{"key":"9827_CR47","volume-title":"Stata statistical software: release 13","author":"StataCorp","year":"2013","unstructured":"StataCorp, Stata statistical software: release 13. 2013, College Station: StataCorp LP."},{"key":"9827_CR48","unstructured":"ICAAC\/American Society for Microbiolog. Effects on compliance and risk of hospitalization in veterans with HIV\/AIDS taking single tablet vs. multiple tablets. 2013, Press release."},{"issue":"Suppl 4","key":"9827_CR49","doi-asserted-by":"crossref","first-page":"18098","DOI":"10.7448\/IAS.15.6.18098","volume":"15","author":"A Antinori","year":"2012","unstructured":"Antinori, A., et al., Adherence in HIV-positive patients treated with single-tablet regimens and multi-pill regimens: findings from the COMPACT study. J Intern AIDS Soc, 2012. 15(Suppl 4): p. 18098.","journal-title":"J Intern AIDS Soc"},{"key":"9827_CR50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12916-014-0142-1","volume":"12","author":"N Langebeek","year":"2014","unstructured":"Langebeek, N., et al., Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med, 2014. 12: p. 142.","journal-title":"BMC Med"},{"issue":"10","key":"9827_CR51","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1080\/09540121.2011.564112","volume":"23","author":"V Senkomago","year":"2011","unstructured":"Senkomago, V., et al., Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda AIDS Care, 2011. 23(10): p. 1246\u201353.","journal-title":"AIDS Care"},{"issue":"3","key":"9827_CR52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00126334-200311010-00004","volume":"34","author":"S Weiser","year":"2003","unstructured":"Weiser, S., et al., Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr, 2003. 34(3): p. 281\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"9827_CR53","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/01.aids.0000327438.13291.62","volume":"22","author":"AP Mahajan","year":"2008","unstructured":"Mahajan, A.P., et al., Stigma in the HIV\/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS, 2008. 22 Suppl 2: p. S67\u201379.","journal-title":"AIDS"},{"issue":"2","key":"9827_CR54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09540121.2010.507741","volume":"23","author":"V Van Tam","year":"2011","unstructured":"Van Tam, V., et al., \"it is not that I forget, it\u2019s just that I don\u2019t want other people to know\": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in northern Vietnam. AIDS Care, 2011. 23(2): p. 139\u201345.","journal-title":"AIDS Care"},{"key":"9827_CR55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-6405-7-2","volume":"7","author":"B Tessema","year":"2010","unstructured":"Tessema, B., et al., Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV\/AIDS in Northwest Ethiopia: a cross-sectional study. AIDS Res Ther, 2010. 7: p. 2.","journal-title":"AIDS Res Ther"},{"issue":"8","key":"9827_CR56","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.socscimed.2008.05.032","volume":"67","author":"WT Steward","year":"2008","unstructured":"Steward, W.T., et al., HIV-related stigma: adapting a theoretical framework for use in India. Soc Sci Med, 2008. 67(8): p. 1225\u201335.","journal-title":"Soc Sci Med"},{"issue":"3","key":"9827_CR57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12160-013-9514-6","volume":"46","author":"AC Tsai","year":"2013","unstructured":"Tsai, A.C., et al., Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med, 2013. 46(3): p. 285\u201394.","journal-title":"Ann Behav Med"},{"issue":"8","key":"9827_CR58","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ijnurstu.2014.01.015","volume":"51","author":"K Lowther","year":"2014","unstructured":"Lowther, K., et al., Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): a systematic review. Int J Nurs Stud, 2014. 51(8): p. 1171\u201389.","journal-title":"Int J Nurs Stud"},{"key":"9827_CR59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-2652-12-15","volume":"12","author":"L Nyblade","year":"2009","unstructured":"Nyblade, L., et al., Combating HIV stigma in health care settings: what works? J Int AIDS Soc, 2009. 12: p. 15.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"9827_CR60","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/pds.1766","volume":"18","author":"BJ Turner","year":"2009","unstructured":"Turner, B.J., et al., Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf, 2009. 18(8): p. 672\u201381.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"9827_CR61","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200203290-00012","volume":"16","author":"GM Lucas","year":"2002","unstructured":"Lucas, G.M., et al., Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 2002. 16(5): p. 767\u201374.","journal-title":"AIDS"},{"issue":"3","key":"9827_CR62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1547-5069.2003.tb00001.x","volume":"35","author":"PV Burkhart","year":"2003","unstructured":"Burkhart, P.V. and E. Sabate, Adherence to long-term therapies: evidence for action. J Nurs Scholarsh, 2003. 35(3): p. 207.","journal-title":"J Nurs Scholarsh"}],"container-title":["Annals of Behavioral Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12160-016-9827-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12160-016-9827-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12160-016-9827-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12160-016-9827-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:00:11Z","timestamp":1749042011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/abm\/article\/51\/1\/67\/4562721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["9827"],"URL":"https:\/\/doi.org\/10.1007\/s12160-016-9827-3","relation":{},"ISSN":["0883-6612","1532-4796"],"issn-type":[{"value":"0883-6612","type":"print"},{"value":"1532-4796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]}}}